readthroughSign in
CompanyHELPNasdaqToronto, A6

Cybin Inc.

Cybin Inc., operating as Helus Pharma, develops proprietary NSAs (synthetic serotonin pathway activators) for mental health.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story

November 2026

October 2026

September 2026

August 2026

July 2026

June 2026